Ocular Hypotensive Efficacy of AR-102

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
A double-masked, randomized, vehicle-controlled, dose-response study assessing the safety and ocular hypotensive efficacy of AR-102 in subjects with elevated intraocular pressure. The Null hypothesis is that the ocular hypotensive efficacy of each dose of AR-102 Ophthalmic Solution will not be different from that of its vehicle.
Epistemonikos ID: 66a7916f9bf4707d86a7de7e8a72cfbcd950f018
First added on: May 04, 2024